Medline Inc
NASDAQ:MDLN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Medline Inc
NASDAQ:MDLN
|
US |
|
Blackmores Ltd
ASX:BKL
|
AU |
|
Green Plains Inc
NASDAQ:GPRE
|
US |
|
B
|
British American Tobacco PLC
OTC:BTAFF
|
UK |
|
Dufry AG
F:D2J
|
CH |
|
Melrose Industries PLC
LSE:MRO
|
UK |
Wall St Price Targets
MDLN Price Targets Summary
Medline Inc
According to Wall Street analysts, the average 1-year price target for MDLN is 52.96 USD with a low forecast of 42.42 USD and a high forecast of 63 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MDLN's stock price target?
Price Target
52.96
USD
According to Wall Street analysts, the average 1-year price target for MDLN is 52.96 USD with a low forecast of 42.42 USD and a high forecast of 63 USD.
What is the Revenue forecast for Medline Inc?
Projected CAGR
8%
Over the last 2 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 5 years is 8%.
What is the Operating Income forecast for Medline Inc?
Projected CAGR
15%
Over the last 2 years, the compound annual growth rate for Operating Income has been 31%. The projected CAGR for the next 5 years is 15%.
What is the Net Income forecast for Medline Inc?
Projected CAGR
23%
Over the last 2 years, the compound annual growth rate for Net Income has been 123%. The projected CAGR for the next 5 years is 23%.
